Company: LIMN
Filing Date: 2025-07-28
Form Type: S-1/A
Source: 0001410578-25-001518
Chunk: 207

Company: Liminatus Pharma, Inc.
Filing Date: 2025-07-28
Form: S-1/A
Chunk 207
---
ated Statements of Cash Flows for the years ended December 31, 2024 and 2023                       | F-14 |
| Notes to Financial Statements                                                                              | F-15 |

| ​                                                                                                                
 Unaudited Financial Statements of Liminatus Pharma, LLC                                                          
 Condensed Balance Sheets as of March 31, 2025 (unaudited) and December 31, 2024                                  
 Unaudited Condensed Statement of Operations for the three months ended March 31, 2025 and 2024                   | ​    
 ​    
 F-19 
 F-20 |
|:-----------------------------------------------------------------------------------------------------------------|:-----|
| Unaudited Condensed Statements of Changes in Members’ Deficit for the three months ended March 31, 2025 and 2024 | F-21 |
| Unaudited Condensed Statements of Cash Flows for the three months ended March 31, 2025 and 2024                  | F-22 |
| Notes to Unaudited Condensed Financial Statements                                                                | F-23 |

| ​                                                                                        | ​    |
| Audited Financial Statements of Liminatus Pharma, LLC                                    | ​    |
| Report of Independent Registered Public Accounting Firm                                  | F-36 |
| Balance Sheets as of December 31, 2024 and 2023                                          | F-37 |
| Statements of Operations for the years ended December 31, 2024 and 2023                  | F-38 |
| Statements of Changes in Members’ Deficit for the years ended December 31, 2024 and 2023 | F-39 |
| Statements of Cash Flows for the years ended December 31, 2024 and 2023                  | F-40 |
| Notes to Financial Statements                                                            | F-41 |

| ​                                                                                                                     
 Unaudited Financial Statements of Iris Acquisition Corp                                                               
 Condensed Balance Sheets as of March 31, 2025 (unaudited) and December 31, 2024                                       
 Unaudited Condensed Statement of Operations for the three months ended March 31, 2025 and 2024                        | ​    
 ​    
 F-53 
 F-54 |
|:----------------------------------------------------------------------------------------------------------------------|:-----|
| Unaudited Condensed Statements of Changes in Stockholders’ Deficit for the three months ended March 31, 2025 and 2024 | F-55 |
| Unaudited Condensed Statements of Cash Flows for the three months ended March